The World Health Organization on Tuesday urged governments to adopt single-dose HPV vaccination and self-collected screening tests. Marking World Cervical Cancer Elimination Day in Geneva, it warned that most countries will miss their 2030 targets. The WHO said cervical cancer still kills a woman roughly every two minutes, with most deaths in sub-Saharan Africa and South Asia.

The day, held on 17 November, was formally recognised by the World Health Assembly in 2025. It marks the anniversary of the WHO's 2020 elimination strategy. That plan set 90-70-90 targets for 2030: 90% of girls vaccinated against HPV by age 15, 70% of women screened with a high-performance test by 35 and again by 45, and 90% of women with cervical disease treated.

According to WHO estimates, the disease caused about 660,000 new cases and 350,000 deaths in 2022. Joint WHO and UNICEF immunisation data published this year showed global first-dose HPV coverage among girls well below half.

Coverage in many low-income countries remains far lower. The WHO said moving to a one-dose schedule, which it endorsed in 2022, has allowed countries to reach more girls with fewer doses.

The WHO also pressed health ministries to replace visual inspection and cytology with HPV DNA testing, including samples women collect themselves. A WHO spokesperson said self-sampling could reach women who never attend clinics, but warned that screening and treatment funding has come under strain after cuts to international aid budgets. Gavi, the Vaccine Alliance, said it would keep supporting HPV programmes in lower-income countries through its current strategic period.

Several wealthier countries used the day to report progress. NHS England has pledged to eliminate cervical cancer by 2040 and is expanding home testing kits for women overdue for screening. Australia remains on course to become one of the first countries to reach elimination, which the WHO defines as fewer than four cases per 100,000 women.